T3 N1 M0 rectal cancer: optimal initial management is total neoadjuvant therapy

被引：0
|
作者：
Nilsson, Per J. [1 ,2 ]
机构：
[1] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden
[2] Karolinska Inst, Dept Mol Med & Surg, Euegeniav 6, Hotellet pl 2, SE-17176 Stockholm, Sweden
来源：
BRITISH JOURNAL OF SURGERY | 2024年 / 111卷 / 01期
关键词：
PREOPERATIVE CHEMORADIOTHERAPY; OPEN-LABEL; CHEMOTHERAPY;
D O I：
10.1093/bjs/znad322
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Rectal cancers T2 N0 M0, rectal preservation: a new field for the clinical research
    Gerard, J. -P.
    Benezery, K.
    Ortholan, C.
    Follana, P.
    Francois, E.
    Hannoun-Levi, J. -M.
    Marcie, S.
    ONCOLOGIE, 2008, 10 (10) : 612 - 616
  • [22] Neoadjuvant radiotherapy improves overall survival for T3/4N+M0 rectal cancer patients: a population-based study of 20300 patients
    Zhao, Feng
    Wang, Jili
    Yu, Hao
    Cheng, Xiaofei
    Li, Xinke
    Zhu, Xuan
    Xu, Xiangming
    Lin, Jianjiang
    Chen, Xin
    Yan, Senxiang
    RADIATION ONCOLOGY, 2020, 15 (01)
  • [23] The Outcome of Postoperative Radiation Therapy for Patients with Stage II Pancreatic Cancer (T3 or N1 Disease)
    Kim, Sang Won
    Chun, Misun
    Kim, Myung Wook
    Kim, Wook-Hwan
    Kang, Seok Yun
    Kang, Seung Hee
    Oh, Young Taek
    Lee, Sunyoung
    Yang, Juno
    RADIATION ONCOLOGY JOURNAL, 2007, 25 (04): : 213 - 218
  • [24] EARLY ANDROGEN ABLATION FOR STAGE D1 (N1 TO N3, M0) PROSTATE-CANCER - PROGNOSTIC VARIABLES AND OUTCOME
    ZAGARS, GK
    SANDS, ME
    POLLACK, A
    VONESCHENBACH, AC
    JOURNAL OF UROLOGY, 1994, 151 (05): : 1330 - 1333
  • [25] Replication error phenotype, clinicopathological variables, and patient outcome in Dukes' B stage II (T3,N0,M0) colorectal cancer
    Curran, B
    Lenehan, K
    Mulcahy, H
    Tighe, O
    Bennett, MA
    Kay, EW
    O'Donoghue, DP
    Leader, M
    Croke, DT
    GUT, 2000, 46 (02) : 200 - 204
  • [26] Preoperative versus postoperative chemoradiotherapy in stage T3, N0 rectal cancer
    Tural, Deniz
    Selcukbiricik, Fatih
    Yildiz, Ozcan
    Elcin, Olgun
    Erdamar, Sibel
    Guney, Sabri
    Demireli, Fuat
    Buyukunal, Evin
    Serdengecti, Suheyla
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (05) : 889 - 896
  • [27] Neoadjuvant radiotherapy improves overall survival for T3/4N+M0 rectal cancer patients: a population-based study of 20300 patients
    Feng Zhao
    Jili Wang
    Hao Yu
    Xiaofei Cheng
    Xinke Li
    Xuan Zhu
    Xiangming Xu
    Jianjiang Lin
    Xin Chen
    Senxiang Yan
    Radiation Oncology, 15
  • [28] Preoperative versus postoperative chemoradiotherapy in stage T3, N0 rectal cancer
    Deniz Tural
    Fatih Selcukbiricik
    Özcan Yıldız
    Olgun Elcin
    Sibel Erdamar
    Sabri Güney
    Fuat Demireli
    Evin Büyükünal
    Süheyla Serdengeçti
    International Journal of Clinical Oncology, 2014, 19 : 889 - 896
  • [29] PT1-T2 N0 M0 BREAST CANCER WITH EARLY RECCURENCE
    Zemni, I.
    Haddad, S.
    Adouni, O.
    Saadallah, F.
    Ben Hassouna, J.
    Hechiche, M.
    Chargui, R.
    Rahal, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A62 - A63
  • [30] Survival Impact of Neoadjuvant Chemotherapy Alone Versus Neoadjuvant Chemoradiation Therapy for Patients With T2N1, T3N0, and T3N1 Rectal Adenocarcinomas
    Cassidy, R. J., III
    Liu, Y.
    Zhong, J.
    Gillespie, T. W.
    Landry, J. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E148 - E148
12345